Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...
Becton Dickinson & Co. closed 3.20% below its 52-week high of $248.42, which the company achieved on March 28th.
S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI ...
Charting, Price Performance, News & Related Contracts.
The Nibiru EVM Upgrade, also called Nibiru V2, is a "purely additive" enhancement to Nibiru that makes it an EVM-equivalent ...
In a recent transaction, Shan David, Executive Vice President and Chief ISC Officer at Becton Dickinson & Co (NYSE:BDX), sold ...
Charting, Price Performance, News & Related Contracts.
Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $237.38 which represents a slight increase of $1.08 or 0.46% from the prior close of $236.3. The stock opened at $236.51 and ...
Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the ...
Becton, Dickinson's stock momentum is improving, but geopolitical risks and global headwinds warrant caution. Click here to ...
Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is proud to announce the launch of Copy Trading ...
Becton Dickinson and Co (BDX) stock saw a decline, ending the day at $232.59 which represents a decrease of $-3.21 or -1.36% from the prior close of $235.8. The stock opened at $237 and touched a low ...